Schizophrenia — Rituximab Treatment for Psychosis and/or Obsessive Compulsive Disorder With Probable Immune System Involvement
Citation(s)
A Randomized, Double-blinded, Placebo-controlled Study of Rituximab in Patients With Psychosis and/or Obsessive Compulsive Disorder, With an Indication of Immune System Involvement